BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giron LB, Dweep H, Yin X, Wang H, Damra M, Goldman AR, Gorman N, Palmer CS, Tang HY, Shaikh MW, Forsyth CB, Balk RA, Zilberstein NF, Liu Q, Kossenkov A, Keshavarzian A, Landay A, Abdel-Mohsen M. Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. Front Immunol 2021;12:686240. [PMID: 34177935 DOI: 10.3389/fimmu.2021.686240] [Cited by in Crossref: 41] [Cited by in F6Publishing: 50] [Article Influence: 41.0] [Reference Citation Analysis]
Number Citing Articles
1 Forsyth CB, Voigt RM, Swanson GR, Bishehsari F, Shaikh M, Zhang L, Engen P, Keshavarzian A. Alcohol use disorder as a potential risk factor for COVID ‐19 severity: A narrative review. Alcohol Clin & Exp Res 2022. [DOI: 10.1111/acer.14936] [Reference Citation Analysis]
2 Rossini V, Tolosa-enguis V, Frances-cuesta C, Sanz Y. Gut microbiome and anti-viral immunity in COVID-19. Critical Reviews in Food Science and Nutrition 2022. [DOI: 10.1080/10408398.2022.2143476] [Reference Citation Analysis]
3 Assante G, Tourna A, Carpani R, Ferrari F, Prati D, Peyvandi F, Blasi F, Bandera A, Le Guennec A, Chokshi S, Patel VC, Cox IJ, Valenti L, Youngson NA. Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell death. Sci Rep 2022;12:18792. [PMID: 36335131 DOI: 10.1038/s41598-022-23282-x] [Reference Citation Analysis]
4 McQuade RM, Bandara M, Diwakarla S, Sahakian L, Han MN, Al Thaalibi M, Di Natale MR, Tan M, Harwood KH, Schneider-Futschik EK, Jarnicki A. Gastrointestinal consequences of lipopolysaccharide-induced lung inflammation. Inflamm Res 2022. [PMID: 36322182 DOI: 10.1007/s00011-022-01657-0] [Reference Citation Analysis]
5 Bernard-Raichon L, Venzon M, Klein J, Axelrad JE, Zhang C, Sullivan AP, Hussey GA, Casanovas-Massana A, Noval MG, Valero-Jimenez AM, Gago J, Putzel G, Pironti A, Wilder E, Thorpe LE, Littman DR, Dittmann M, Stapleford KA, Shopsin B, Torres VJ, Ko AI, Iwasaki A, Cadwell K, Schluter J; Yale IMPACT Research Team. Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nat Commun 2022;13:5926. [PMID: 36319618 DOI: 10.1038/s41467-022-33395-6] [Reference Citation Analysis]
6 Naryzhny S, Legina O. Zonulin — regulation of tight contacts in the brain and intestine — facts and hypotheses. BIOMED KHIM 2022;68:309-320. [DOI: 10.18097/pbmc20226805309] [Reference Citation Analysis]
7 Lau RI, Zhang F, Liu Q, Su Q, Chan FKL, Ng SC. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nat Rev Gastroenterol Hepatol 2022. [PMID: 36271144 DOI: 10.1038/s41575-022-00698-4] [Reference Citation Analysis]
8 Yeung ST, Premeaux TA, Du L, Niki T, Pillai SK, Khanna KM, Ndhlovu LC. Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection. Front Immunol 2022;13:1011185. [DOI: 10.3389/fimmu.2022.1011185] [Reference Citation Analysis]
9 Forsyth CB, Zhang L, Bhushan A, Swanson B, Zhang L, Mamede JI, Voigt RM, Shaikh M, Engen PA, Keshavarzian A. The SARS-CoV-2 S1 Spike Protein Promotes MAPK and NF-kB Activation in Human Lung Cells and Inflammatory Cytokine Production in Human Lung and Intestinal Epithelial Cells. Microorganisms 2022;10:1996. [DOI: 10.3390/microorganisms10101996] [Reference Citation Analysis]
10 Palmer CS. Innate metabolic responses against viral infections. Nat Metab 2022;4:1245-59. [PMID: 36266542 DOI: 10.1038/s42255-022-00652-3] [Reference Citation Analysis]
11 Clerbaux L, Mayasich SA, Muñoz A, Soares H, Petrillo M, Albertini MC, Lanthier N, Grenga L, Amorim M. Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. JCM 2022;11:5691. [DOI: 10.3390/jcm11195691] [Reference Citation Analysis]
12 Ayechu-Muruzabal V, Poelmann B, Berends AJ, Kettelarij N, Garssen J, Van't Land B, Willemsen LEM. Human Milk Oligosaccharide 2'-Fucosyllactose Modulates Local Viral Immune Defense by Supporting the Regulatory Functions of Intestinal Epithelial and Immune Cells. Int J Mol Sci 2022;23:10958. [PMID: 36142892 DOI: 10.3390/ijms231810958] [Reference Citation Analysis]
13 Clerbaux L, Fillipovska J, Muñoz A, Petrillo M, Coecke S, Amorim M, Grenga L. Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways. JCM 2022;11:5400. [DOI: 10.3390/jcm11185400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Palomino-kobayashi LA, Ymaña B, Ruiz J, Mayanga-herrera A, Ugarte-gil MF, Pons MJ. Zonulin, a marker of gut permeability, is associated with mortality in a cohort of hospitalised peruvian COVID-19 patients. Front Cell Infect Microbiol 2022;12:1000291. [DOI: 10.3389/fcimb.2022.1000291] [Reference Citation Analysis]
15 Russo A, Serapide F, Quirino A, Tarsitano MG, Marascio N, Serraino R, Rotundo S, Matera G, Trecarichi EM, Torti C. Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut Microbiota. Diagnostics 2022;12:2143. [DOI: 10.3390/diagnostics12092143] [Reference Citation Analysis]
16 Okuyucu M, Yalcin Kehribar D, Çapraz M, Çapraz A, Arslan M, Çelik ZB, Usta B, Birinci A, Ozgen M. The Relationship Between COVID-19 Disease Severity and Zonulin Levels. Cureus 2022. [DOI: 10.7759/cureus.28255] [Reference Citation Analysis]
17 Pandrea I, Brooks K, Desai RP, Tare M, Brenchley JM, Apetrei C. I’ve looked at gut from both sides now: Gastrointestinal tract involvement in the pathogenesis of SARS-CoV-2 and HIV/SIV infections. Front Immunol 2022;13:899559. [DOI: 10.3389/fimmu.2022.899559] [Reference Citation Analysis]
18 Wais T, Hasan M, Rai V, Agrawal DK. Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics. Expert Rev Clin Immunol 2022. [PMID: 35868344 DOI: 10.1080/1744666X.2022.2105697] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ailioaie LM, Ailioaie C, Litscher G, Chiran DA. Celiac Disease and Targeting the Molecular Mechanisms of Autoimmunity in COVID Pandemic. IJMS 2022;23:7719. [DOI: 10.3390/ijms23147719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Noval Rivas M, Porritt RA, Cheng MH, Bahar I, Arditi M. Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis. Front Immunol 2022;13:941009. [DOI: 10.3389/fimmu.2022.941009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
21 Blaize M, Raoelina A, Kornblum D, Kamus L, Lampros A, Berger M, Demeret S, Constantin J, Monsel A, Mayaux J, Luyt C, Piarroux R, Fekkar A. Occurrence of Candidemia in Patients with COVID-19 Admitted to Five ICUs in France. JoF 2022;8:678. [DOI: 10.3390/jof8070678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Jedrzejak AP, Urbaniak EK, Wasko JA, Ziojla N, Borowiak M. Diabetes and SARS-CoV-2–Is There a Mutual Connection? Front Cell Dev Biol 2022;10:913305. [DOI: 10.3389/fcell.2022.913305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Assimakopoulos SF, Eleftheriotis G, Lagadinou M, Karamouzos V, Dousdampanis P, Siakallis G, Marangos M. SARS CoV-2-Induced Viral Sepsis: The Role of Gut Barrier Dysfunction. Microorganisms 2022;10:1050. [DOI: 10.3390/microorganisms10051050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Jackson A, Engen PA, Forsyth CB, Shaikh M, Naqib A, Wilber S, Frausto DM, Raeisi S, Green SJ, Bradaric BD, Persons AL, Voigt RM, Keshavarzian A. Intestinal Barrier Dysfunction in the Absence of Systemic Inflammation Fails to Exacerbate Motor Dysfunction and Brain Pathology in a Mouse Model of Parkinson's Disease. Front Neurol 2022;13:882628. [DOI: 10.3389/fneur.2022.882628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Albrich WC, Ghosh TS, Ahearn-ford S, Mikaeloff F, Lunjani N, Forde B, Suh N, Kleger G, Pietsch U, Frischknecht M, Garzoni C, Forlenza R, Horgan M, Sadlier C, Negro TR, Pugin J, Wozniak H, Cerny A, Neogi U, O’toole PW, O’mahony L. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2. Gut Microbes 2022;14:2073131. [DOI: 10.1080/19490976.2022.2073131] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
26 Escarcega RD, Honarpisheh P, Colpo GD, Ahnstedt HW, Couture L, Juneja S, Torres G, Ortiz GJ, Sollome J, Tabor N, Ganesh BP, Choi HA, Liu F, McCullough LD, Tsvetkov AS. Sex differences in global metabolomic profiles of COVID-19 patients. Cell Death Dis 2022;13:461. [PMID: 35568706 DOI: 10.1038/s41419-022-04861-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Jiang Y, Deng Y, Pang H, Ma T, Ye Q, Chen Q, Chen H, Hu Z, Qin CF, Xu Z. Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models. Cell Discov 2022;8:38. [PMID: 35487885 DOI: 10.1038/s41421-022-00409-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Giron LB, Peluso MJ, Ding J, Kenny G, Zilberstein NF, Koshy J, Hong KY, Rasmussen H, Miller G, Bishehsari F, Balk RA, Moy JN, Hoh R, Lu S, Goldman AR, Tang H, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Kelly JD, Wasse H, Martin JN, Liu Q, Keshavarzian A, Landay A, Deeks SG, Henrich TJ, Abdel-mohsen M. Markers of Fungal Translocation Are Elevated During Post-Acute Sequelae of SARS-CoV-2 Infection and Induce NF-κB Triggered Inflammation.. [DOI: 10.1101/2022.04.12.488051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Castañé H, Iftimie S, Baiges-gaya G, Rodríguez-tomàs E, Jiménez-franco A, López-azcona AF, Garrido P, Castro A, Camps J, Joven J. Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients. Metabolism 2022. [DOI: 10.1016/j.metabol.2022.155197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
30 Lunjani N, Albrich WC, Suh N, Barda B, Finnegan LA, Dam SA, Walter J, Sadlier C, Horgan M, O'Toole PW, O'Mahony L. Higher levels of bacterial DNA in serum associate with severe and fatal COVID-19. Allergy 2022;77:1312-4. [PMID: 35020222 DOI: 10.1111/all.15218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
31 Martel J, Chang SH, Ko YF, Hwang TL, Young JD, Ojcius DM. Gut barrier disruption and chronic disease. Trends Endocrinol Metab 2022;33:247-65. [PMID: 35151560 DOI: 10.1016/j.tem.2022.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
32 Caputo A, Guzman CA, Palmer CS, Nicoli F. Editorial: The Role of Systemic and Cellular Metabolism on Susceptibility to Infections and Responsiveness to Vaccination. Front Cell Infect Microbiol 2022;12:854241. [DOI: 10.3389/fcimb.2022.854241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Venzon M, Bernard-Raichon L, Klein J, Axelrad JE, Zhang C, Hussey GA, Sullivan AP, Casanovas-Massana A, Noval MG, Valero-Jimenez AM, Gago J, Putzel G, Pironti A, Wilder E, Thorpe LE, Littman DR, Dittmann M, Stapleford KA, Shopsin B, Torres VJ, Ko AI, Iwasaki A, Cadwell K, Schluter J; Yale IMPACT Research Team. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation. bioRxiv 2022:2021. [PMID: 35262080 DOI: 10.1101/2021.07.15.452246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
34 Castañé H, Iftimie S, Baiges-gaya G, Rodríguez-tomàs E, Jiménez-franco A, López-azcona AF, Garrido P, Castro A, Camps J, Joven J. Machine learning identified distinct serum lipidomic signatures in hospitalized COVID-19-positive and COVID-19-negative patients.. [DOI: 10.1101/2021.12.14.21267764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK. COVID-19 and gut immunomodulation. World J Gastroenterol 2021; 27(46): 7925-7942 [DOI: 10.3748/wjg.v27.i46.7925] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
36 Bhalla S, Sharma B, Smith D, Boley R, McCluskey C, Ilyas Y, Afshar M, Balk R, Karnik N, Keshavarzian A. Investigating Unhealthy Alcohol Use As an Independent Risk Factor for Increased COVID-19 Disease Severity: Observational Cross-sectional Study. JMIR Public Health Surveill 2021;7:e33022. [PMID: 34665758 DOI: 10.2196/33022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
37 Morse ZJ, Horwitz MS. Virus Infection Is an Instigator of Intestinal Dysbiosis Leading to Type 1 Diabetes. Front Immunol 2021;12:751337. [PMID: 34721424 DOI: 10.3389/fimmu.2021.751337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Albrich WC, Ghosh TS, Ahearn-ford S, Mikaeloff F, Lunjani N, Forde B, Suh N, Kleger G, Pietsch U, Frischknecht M, Garzoni C, Forlenza R, Horgan M, Sadlier C, Negro TR, Pugin J, Wozniak H, Cerny A, Neogi U, O’toole PW, O’mahony L. Excessive inflammatory and metabolic responses to acute SARS-CoV-2 infection are associated with a distinct gut microbiota composition.. [DOI: 10.1101/2021.10.26.465865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Zuo T, Wu X, Wen W, Lan P. Gut Microbiome Alterations in COVID-19. Genomics Proteomics Bioinformatics 2021:S1672-0229(21)00206-0. [PMID: 34560321 DOI: 10.1016/j.gpb.2021.09.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
40 Bhalla S, Sharma B, Smith D, Boley R, Mccluskey C, Ilyas Y, Afshar M, Balk R, Karnik N, Keshavarzian A. Investigating Unhealthy Alcohol Use As an Independent Risk Factor for Increased COVID-19 Disease Severity: Observational Cross-sectional Study (Preprint).. [DOI: 10.2196/preprints.33022] [Reference Citation Analysis]
41 Johnson SD, Olwenyi OA, Bhyravbhatla N, Thurman M, Pandey K, Klug EA, Johnston M, Dyavar SR, Acharya A, Podany AT, Fletcher CV, Mohan M, Singh K, Byrareddy SN. Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis. World J Gastroenterol 2021; 27(29): 4763-4783 [PMID: 34447225 DOI: 10.3748/wjg.v27.i29.4763] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
42 Moreira JLS, Barbosa SMS, Gonçalves Júnior J. Pathophysiology and molecular mechanisms of liver injury in severe forms of COVID-19: An integrative review. Clin Res Hepatol Gastroenterol 2021;45:101752. [PMID: 34303828 DOI: 10.1016/j.clinre.2021.101752] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
43 Pérez-Gómez A, Vitallé J, Gasca-Capote C, Gutierrez-Valencia A, Trujillo-Rodriguez M, Serna-Gallego A, Muñoz-Muela E, Jiménez-Leon MLR, Rafii-El-Idrissi Benhnia M, Rivas-Jeremias I, Sotomayor C, Roca-Oporto C, Espinosa N, Infante-Domínguez C, Crespo-Rivas JC, Fernández-Villar A, Pérez-González A, López-Cortés LF, Poveda E, Ruiz-Mateos E; Virgen del Rocío Hospital COVID-19 Working Team. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cell Mol Immunol 2021. [PMID: 34290398 DOI: 10.1038/s41423-021-00728-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 29.0] [Reference Citation Analysis]
44 Hensley-McBain T, Manuzak JA. Zonulin as a biomarker and potential therapeutic target in multisystem inflammatory syndrome in children. J Clin Invest 2021;131:151467. [PMID: 34160366 DOI: 10.1172/JCI151467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Vestad B, Ueland T, Lerum TV, Børresdatter Dahl T, Holm K, Barratt-due A, Kåsine T, Dyrhol-riise AM, Stiksrud B, Tonby K, Hoel H, Olsen IC, Henriksen KN, Tveita A, Manotheepan R, Haugli M, Eiken R, Berg Å, Halvorsen B, Lekva T, Ranheim T, Michelsen AE, Kildal AB, Johannessen A, Thoresen L, Skudal H, Kittang BR, Bjørkholt Olsen R, Ystrøm CM, Skei NV, Hannula R, Aballi S, Kvåle R, Skjønsberg OH, Aukrust P, Hov JR, Trøseid M. Gut microbiota alterations in patients with persistent respiratory dysfunction three months after severe COVID-19.. [DOI: 10.1101/2021.07.13.21260412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]